Precision Drug Development
Accelerate drug development timelines, reduce risks and lower costs
Our biosimulation platform predicts human clinical response to investigational drug candidates YEARS earlier than traditional development pipelines
Use biosimulation technology to maximize your drug development success
ACCELERATE Drug approval timelines
BOOST Clinical Trial Success Rates
EXPAND Markets via non-obvious indications
REVIVE Deprioritized and Shelved Assets
Our drug development biosimulation methodology
The Cellworks Platform is powered by the groundbreaking Cellworks Computational Biology Model (CBM), a network of 6,000+ human genes, 30,000+ molecular species and 600,000+ molecular interactions.
Cellworks precision drug development addresses key industry challenges
Improve drug success rates through biomarker development
Identify companion molecules to expand the utility of a drug
Expand indications for drugs at the pre-clinical stage
